1-(1H-Pyrazol-1-yl)propan-2-amine structure
|
Common Name | 1-(1H-Pyrazol-1-yl)propan-2-amine | ||
|---|---|---|---|---|
| CAS Number | 57939-04-5 | Molecular Weight | 125.17200 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C6H11N3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Name | 1-(1H-Pyrazol-1-yl)-2-propanamine |
|---|---|
| Synonym | More Synonyms |
| Molecular Formula | C6H11N3 |
|---|---|
| Molecular Weight | 125.17200 |
| Exact Mass | 125.09500 |
| PSA | 43.84000 |
| LogP | 0.93060 |
|
~%
1-(1H-Pyrazol-1... CAS#:57939-04-5 |
| Literature: NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; Location in patent: Page/Page column 111 ; WO 2012/018635 A2 |
|
~96%
1-(1H-Pyrazol-1... CAS#:57939-04-5 |
| Literature: CONCERT PHARMACEUTICALS INC.; Tung, Roger Patent: US2014/128469 A1, 2014 ; Location in patent: Paragraph 0110; 0112 ; |
|
~%
1-(1H-Pyrazol-1... CAS#:57939-04-5 |
| Literature: NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; WO 2012/018635 A2 |
|
~%
1-(1H-Pyrazol-1... CAS#:57939-04-5 |
| Literature: NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; WO 2012/018635 A2 |
| 4-Methyl-3-nitro-benzoesaeure-methylester |
| 3-nitro-4-phenoxy-5-sulphamylbenzoic acid methyl ester |
| methyl 3-nitro-4-phenoxy-5-sulfamoylbenzoate |
| Methyl 3-nitro-p-toluate |
| Methyl 3-nitro-4-methylbenzoate |
| 3-nitro-4-phenoxy-5-sulfamoylbenzoic acid methyl ester |
| 4-Methyl-3-nitrobenzoic acid methyl ester |